1991
DOI: 10.1001/archderm.127.9.1420
|View full text |Cite
|
Sign up to set email alerts
|

Low-dose cyclosporine A in the treatment of disabling morphea

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0
2

Year Published

1997
1997
2017
2017

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 15 publications
(10 citation statements)
references
References 0 publications
0
8
0
2
Order By: Relevance
“…In this disease, the various systemic treatments employed, including corticosteroids, non‐steroidal anti‐inflammatory drugs, penicillin, and cyclosporine, have met with only limited success (6, 7). Ultraviolet A irradiation increases collagenase activity in human dermal fibroblasts (8).…”
Section: Discussionmentioning
confidence: 99%
“…In this disease, the various systemic treatments employed, including corticosteroids, non‐steroidal anti‐inflammatory drugs, penicillin, and cyclosporine, have met with only limited success (6, 7). Ultraviolet A irradiation increases collagenase activity in human dermal fibroblasts (8).…”
Section: Discussionmentioning
confidence: 99%
“…Numerous other systemics have been reported in cases of LS, including cyclosporine A, azathioprine, chloroquine and hydroxychloroquine, phenytoin, colchicine, retinoids, intravenous immunoglobulins (IVIg), abatacept, infliximab, rituximab or imatinib . These treatments should be reserved to single severe cases with contraindications or failure to standard therapy.…”
Section: Localized Scleroderma (Morphea)mentioning
confidence: 99%
“…Numerous other systemics have reported in cases of LS, including infliximab, bosentan, antimalarial drugs, imatinib, extracorporeal photopheresis, cyclosporine, and penicillin, but none of them has so far been confirmed in a larger number of subjects .…”
Section: Treatmentmentioning
confidence: 99%